Seco-Cervera, M.; González-Cabo, P.; Pallardó, F.V.; Romá-Mateo, C.; García-Giménez, J.L.
Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich’s Ataxia. Antioxidants 2020, 9, 1257.
https://doi.org/10.3390/antiox9121257
AMA Style
Seco-Cervera M, González-Cabo P, Pallardó FV, Romá-Mateo C, García-Giménez JL.
Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich’s Ataxia. Antioxidants. 2020; 9(12):1257.
https://doi.org/10.3390/antiox9121257
Chicago/Turabian Style
Seco-Cervera, Marta, Pilar González-Cabo, Federico V. Pallardó, Carlos Romá-Mateo, and José Luis García-Giménez.
2020. "Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich’s Ataxia" Antioxidants 9, no. 12: 1257.
https://doi.org/10.3390/antiox9121257
APA Style
Seco-Cervera, M., González-Cabo, P., Pallardó, F. V., Romá-Mateo, C., & García-Giménez, J. L.
(2020). Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich’s Ataxia. Antioxidants, 9(12), 1257.
https://doi.org/10.3390/antiox9121257